Patients with Atrial Fibrillation in Clinical Practice: Comorbidity, Drug Treatment and Outcomes (Data from RECVASA Registries)

Patients with Atrial Fibrillation in Clinical Practice: Comorbidity, Drug Treatment and Outcomes (Data from RECVASA Registries)

Aim. To study comorbidity, drug therapy and outcomes in patients with atrial fibrillation (AF) included in the outpatient and hospital RECVASA registries.Material and methods. Patients with AF (n=3169; age 70.9±10.7 years; 43.1% of men) in whom comorbidity, drug therapy, short-term and longterm outc...

ver descrição completa

Detalhes bibliográficos
Principais autores:	M. M. Loukianov, E. Yu. Andreenko, S. Yu. Martsevich, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, E. Yu. Okshina, V. V. Yakusevich, V. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. N. Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, V. G. Klyashtorny, E. V. Kudryashov, Ju. E. Tatsii, S. A. Boytsov, O. M. Drapkina
Formato:	Artigo
Idioma:	English
Publicado em:	Столичная издательская компания 2020-12-01
coleção:	Рациональная фармакотерапия в кардиологии
Assuntos:	atrial fibrillation outpatient and hospital registries comorbidity drug treatment prospective monitoring outcomes mortality
Acesso em linha:	https://www.rpcardio.online/jour/article/view/2349

Registros relacionados

The Therapy with Oral Anticoagulants in Patients with Atrial Fibrillation in Outpatient and Hospital Settings (Data from RECVASA Registries)
por: M. M. Loukianov, et al.
Publicado em: (2019-09-01)

THE CONTROL OF INTERNATIONAL NORMALISED RATIO IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH WARFARIN IN OUTPATIENT AND HOSPITAL SETTINGS: DATA FROM RECVASA REGISTRIES
por: M. M. Loukianov, et al.
Publicado em: (2018-03-01)

PATIENTS WITH ATRIAL FIBRILLATION IN MULTIDISCIPLINARY HOSPITAL: STRUCTURE OF HOSPITALIZATION, CONCOMITANT CARDIOVASCULAR DISEASES AND DRUG TREATMENT (DATA OF RECVASA AF-TULA REGISTRY)
por: M. N. Valiakhmetov, et al.
Publicado em: (2017-09-01)

Patients with a Combination of Atrial Fibrillation and Chronic Heart Failure in Clinical Practice: Comorbidities, Drug Treatment and Outcomes
por: M. M. Loukianov, et al.
Publicado em: (2022-01-01)

Combination of Atrial Fibrillation and Coronary Heart Disease in Patients in Clinical Practice: Comorbidities, Pharmacotherapy and Outcomes (Data from the REСVASA Registries)
por: M. M. Loukianov, et al.
Publicado em: (2021-11-01)

CONCOMITANT CARDIOVASCULAR DISEASES AND ANTIHYPERTENSIVE TREATMENT IN OUTPATIENT PRACTICE (BY THE RECVASA REGISTRY DATA)
por: M. M. Loukianov, et al.
Publicado em: (2016-03-01)

Young ambulatory patients with cardiovascular diseases: age and gender characteristics, comorbidity, medication and outcomes (according to RECVASA register)
por: E. Yu. Andreenko, et al.
Publicado em: (2019-12-01)

PATIENTS WITH COMBINATION OF CHRONIC HEART FAILURE, HYPERTENSION AND HISTORY OF MYOCARDIAL INFARCTION: CLINICAL AND ANAMNESTIC CHARACTERISTICS, ADMINISTRATION OF ACE INHIBITORS, ANGIOTENSIN RECEPTOR BLOCKERS, -BLOCKERS AND ADHERENCE TO THE DRUG THERAPY (DATA OF OUTPATIENT REGISTRY RECVASA)
por: M. M. Loukianov, et al.
Publicado em: (2017-05-01)

QUALITY ASSESSMENT OF ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION WITHOUT CONCOMITANT CARDIOVASCULAR DISEASES AS A PART OF OUTPATIENT RECVASA REGISTER
por: A. V. Zagrebelnyy, et al.
Publicado em: (2015-09-01)

OUTPATIENT REGISTRY OF CARDIOVASCULAR DISEASES (RECVASA): PROSPECTIVE FOLLOW-UP DATA, ESTIMATION OF RISKS AND OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION
por: M. M. Loukianov, et al.
Publicado em: (2015-09-01)

AN OUTPATIENT WITH ATRIAL FIBRILLATION: KEY FEATURES. THE FIRST DATA OF REKVAZA FP - YAROSLAVL REGISTER
por: V. V. Yakusevich, et al.
Publicado em: (2015-09-01)

PATIENTS WITH ATRIAL FIBRILLATION AND ISCHEMIC HEART DISEASE: HOSPITALIZATION STRUCTURE AND ANTITHROMBOTIC THERAPY (RECVASA AF-KURSK REGISTRY)
por: V. P. Mikhin, et al.
Publicado em: (2017-05-01)

DIAGNOSTICS, TREATMENT, ASSOCIATED CARDIOVASCULAR AND CONCOMITANT NON-CARDIAC DISEASES IN PATIENTS WITH DIAGNOSIS OF “ATRIAL FIBRILLATION” IN REAL OUTPATIENT PRACTICE (ACCORDING TO DATA OF REGISTRY OF CARDIOVASCULAR DISEASES, RECVASA)
por: M. M. Loukianov, et al.
Publicado em: (2015-09-01)

Outpatient Registry REGION: Prospective Follow-up Data and Outcomes in Patients After Acute Cerebrovascular Accident
por: M. M. Loukianov, et al.
Publicado em: (2020-01-01)

DIAGNOSIS AND TREATMENT OF PATIENTS WITH SEVERE HYPERCHOLESTEROLEMIA IN REAL OUTPATIENT PRACTICE (ACCORDING TO THE RECVASA REGISTRY)
por: A. I. Ershova, et al.
Publicado em: (2015-09-01)

Patients with Premature Cardiovascular Diseases in Ambulatory Practice: Demographic Characteristics, Risk Factors and Adherence to the Medical Therapy (Data of RECVASA Registry)
por: E. Yu. Andreenkо, et al.
Publicado em: (2020-05-01)

THE OUTPATIENT BASED REGISTRY RECVASA: PROSPECTIVE FOLLOW-UP DATA, RISK EVLUATION AND OUTCOMES IN CARDIOVASCULAR PATIENTS
por: S. A. Boytsov, et al.
Publicado em: (2015-02-01)

Patients with Combination of Cardiovascular Diseases and Type 2 Diabetes in RECVASA and REGION Registries: Multimorbidity, Outcomes and Potential Effect of Dapagliflozin in the Russian Clinical Practice
por: M. M. Loukianov, et al.
Publicado em: (2020-03-01)

COMBINED ANTIHYPERTENSIVE THERAPY IN REAL CLINICAL PRACTICE. FOCUS ON FIXED COMBINATIONS OF ANTIHYPERTENSIVE DRUGS (According to the Data of Outpatient Registries RECVASA and PROFILE)
por: S. Yu. Martsevich, et al.
Publicado em: (2017-07-01)

Cardiovascular Diseases and Drug Treatment in Patients with the History of Cerebral Stroke: Data of the Outpatient Registry REGION
por: M. M. Loukianov, et al.
Publicado em: (2019-01-01)

ORAL ANTICOAGULANTS IN AMBULATORY AND IN-HOSPITAL TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION ASSOCIATED WITH HYPERTENSION, ISCHEMIC HEART DISEASE AND CHRONIC HEART FAILURE: DATA FROM HOSPITAL REGISTRY RECVASA-CLINIC
por: E. V. Stepina, et al.
Publicado em: (2017-05-01)

ROLE OF THE ANTIPLATELET DRUGS IN TREATMENT OF STABLE ANGINA: COMMON SENSE AND NON-RESOLVED ISSUES
por: V. V. Yakusevich, et al.
Publicado em: (2015-07-01)

CLINICAL PRACTICE OF BETA-BLOCKERS USAGE IN PATIENTS WITH CARDIOVASCULAR AND CHRONIC RESPIRATORY DISEASES. DATA OF OUTPATIENT REGISTRIES PROFILE AND RECVASA
por: S. Yu. Martsevich, et al.
Publicado em: (2017-09-01)

DRUG TREATMENT OF PATIENTS WITH THE HISTORY OF ACUTE STROKE: DATA OF THE PILOT PHASE OF THE OUTPATIENT REGISTRY «REGION»
por: S. A. Boytsov, et al.
Publicado em: (2017-07-01)

OUTPATIENT REGISTER OF CARDIOVASCULAR DISEASES IN THE RYAZAN REGION (RECVASA): PRINCIPAL TASKS, EXPERIENCE OF DEVELOPMENT AND FIRST RESULTS
por: S. A. Boytsov, et al.
Publicado em: (2015-09-01)

Patients with History of Myocardial Infarction and Acute Cerebrovascular Accidentin Clinical Practice: Demographic, Clinical Characteristics, Drug Treatment and Outcomes (Data of Outpatient and Hospital Registry REGION)
por: E. Yu. Okshina, et al.
Publicado em: (2019-11-01)

COMPARATIVE CHARACTERISTICS OF MULTIMORBIDITY, DRUG TREATMENT AND OUTCOMES IN POSTSTROKE PATIENTS WITH ATRIAL FIBRILLATION AND WITH OR WITHOUT HISTORY OF MYOCARDIAL INFARCTION (REGISTRY REGION DATA)
por: E. Yu. Okshina, et al.
Publicado em: (2020-01-01)

Patients with atrial fibrillation in outpatient practice: clinical characteristics and outcomes over a 10-year observation period (data from the REQUAZA AF registrу — Yaroslavl)
por: V. V. Yakusevich, et al.
Publicado em: (2023-11-01)

Early cardiovascular multimorbidity in out- and in-patient care: age characteristics and medication therapy (data from the REKVAZA and REKVAZA-CLINIC registries)
por: E. Yu. Andreenko, et al.
Publicado em: (2020-11-01)

Comparative Characteristics of Patients with Cerebral Stroke and Myocardial Infarction in Outpatient Practice: Structure of Comorbidity, Risk Factors, Drug Treatment and Outcomes
por: A. N. Vorobyev, et al.
Publicado em: (2020-11-01)

THE STUDY "REGISTER OF PATIENTS AFTER ACUTE STROKE (REGION)". PART 2. OUTPATIENT PROSPECTIVE REGISTER OF PATIENTS AFTER ACUTE STROKE (ACCORDING TO THE RESULTS OF THE PILOT PHASE OF THE STUDY)
por: S. А. Boytsov, et al.
Publicado em: (2017-03-01)

CONCOMITANT CARDIOVASCULAR DISEASES AND ANTIHYPERTENSIVE TREATMENT IN OUTPATIENT PRACTICE (BY THE RECVASA REGISTRY DATA)
por: M. Loukianov
Publicado em: (2017-01-01)

Indap effectiveness and tolerability, in comparison to arifon and arifon retard, as monotherapy or in combination with ACE inhibitors, among patients with mild to moderate arterial hypertension. Multi-center, open, randomized, cross-over study
por: S. Yu. Martsevich, et al.
Publicado em: (2006-04-01)

Conceptual approaches to cerebral blood flow correction in postmenopausal women with arterial hypertension
por: V. V. Yakusevich, et al.
Publicado em: (2005-04-01)

Prehospital Period in Patients with COVID-19: Cardiovascular Comorbidity and Pharmacotherapy During the First Epidemic Wave (Hospital Registry Data)
por: S. Yu. Martsevich, et al.
Publicado em: (2022-01-01)

HEMORHEOLOGICAL PROFILE AND LIPID SPECTRUM IN PATIENTS IN THE ACUTE PHASE OF ISCHEMIC STROKE
por: V. V. Yakusevich, et al.
Publicado em: (2014-07-01)

Medical treatment of patients with cardiovascular diseases during the first year after hospitalization for COVID-19
por: N. P. Kutishenko, et al.
Publicado em: (2023-01-01)

Detection rate and characteristics of heart failure, depending on the diagnostic criteria in COVID-19 survivors one year after hospitalization
por: Yu. V. Mareev, et al.
Publicado em: (2023-01-01)

Long-term outcomes in patients after COVID-19: data from the TARGET-VIP registry
por: M. M. Lukyanov, et al.
Publicado em: (2022-04-01)

Dynamics of age characteristics and prevalence of concomitant cardiovascular and non-sardiovascular diseases in patients hospitalized with COVID-19 during epidemic wave: data from TARGET-VIP registry
por: M. M. Lukyanov, et al.
Publicado em: (2022-01-01)